Physician profile
Edward Smith
NPI 1174542781
$959.84
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $92.67 · 2021: $102 · 2022: $229.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $112.82 | 2019-2022 | |
| Glaxosmithkline, LLC. | $86.25 | 2022 | |
| Seagen INC. | $85.53 | 2019-2021 | |
| Incyte Corporation | $63.81 | 2022 | |
| Taiho Oncology, INC. | $62.39 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $61.19 | 2019-2021 | |
| Amgen INC. | $55.83 | 2019-2021 | |
| Celgene Corporation | $48.28 | 2019 | |
| Merck Sharp & Dohme LLC | $46.79 | 2019 | |
| Emd Serono, INC. | $44.46 | 2019-2020 | |
| Genentech USA, INC. | $44.03 | 2019 | |
| Alexion Pharmaceuticals, INC. | $36.47 | 2019 | |
| Lilly USA, LLC | $31.69 | 2019 | |
| Daiichi Sankyo INC. | $31.11 | 2020 | |
| Gilead Sciences, INC. | $25.44 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.24 | 2019 | |
| Amag Pharmaceuticals, INC. | $19.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.49 | 2019 | |
| Janssen Biotech, INC. | $15.35 | 2021 | |
| Rigel Pharmaceuticals, INC. | $13.83 | 2019 | |
| Pfizer INC. | $13.50 | 2019 | |
| Csl Behring | $11.49 | 2020 | |
| Agios Pharmaceuticals, INC. | $11.07 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.